Harrison, Stephanie L. http://orcid.org/0000-0002-8846-0946
Buckley, Benjamin J.R.
Lane, Deirdre A.
Fazio-Eynullayeva, Elnara
Underhill, Paula
Hill, Andrew
Werring, David J.
Lip, Gregory Y.H.
Article History
Accepted: 18 January 2023
First Online: 24 January 2023
Declarations
:
: As a federated network, research studies using the TriNetX research network do not require ethical approvals as no patient identifiable identification is received.
: Not applicable
: Not applicable
: Stephanie L Harrison has received funding from Bristol-Myers Squibb (BMS). Benjamin JR Buckley has received research funding from BMS/Pfizer. Deirdre A Lane has received investigator-initiated educational grants from Bristol-Myers Squibb (BMS), has been a speaker for Bayer, Boehringer Ingelheim and BMS/Pfizer and has consulted for BMS and Boehringer Ingelheim. Elnara Fazio-Eynullayeva and Paula Underhill are employees of TriNetX Inc. Andrew Hill declares no conflicts of interest. David Werring has received personal fees outside the submitted work, from Bayer, Portola, Alnylam and Novo Nordisk. Gregory YH Lip has been a consultant for Bayer/Janssen, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon and Daiichi-Sankyo and speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim and Daiichi-Sankyo. No fees are directly received by Gregory Lip personally.